TP53 and cancer: Bioinformatics analysis based on TCGA data showed that the MDM2 gene was highly expressed in p53 wild-type NSCLC compared to p53 mutant NSCLC, implying that MDM2 overexpression may be beneficial for p53 wild-type cancer growth.